Despite an emphasis on clinical practice guidelines based on evidence from randomized clinical trials, medicine in many ways remains an inexact science. The limits of evidence-based medicine are apparent, including knowledge gaps from lack of high-quality clinical data.1 Moreover, the “one size fits all” strategy, designed for the average patient, is hampered by the biological variability that leads to heterogeneity in disease expression.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Arnar DO, Palsson R. Precision Medicine and Advancing Clinical Care: Insights From Iceland. JAMA Intern Med. Published online December 10, 2018. doi:10.1001/jamainternmed.2018.6729
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: